Xiao Wu

Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder

Armin Szegedi, Suresh Durgam, Mary Mackle et al. · American Journal of Psychiatry · 2017 · 66 citations · Full text

Medicine, Pharmacology, Psychiatry +14

Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial

Robert L. Findling, Ronald L. Landbloom, Mary Mackle et al. · Pediatric Drugs · 2016 · 53 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control

Ronald Landbloom, Mary Mackle, Xiao Wu et al. · CNS Spectrums · 2016 · 33 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Asenapine: Efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder

Ronald L. Landbloom, Mary Mackle, Xiao Wu et al. · Journal of Affective Disorders · 2015 · 32 citations

Medicine, Pharmacology, Psychiatry +6

Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD

James F. Donohue, Weily Soong, Xiao Wu et al. · Respiratory Medicine · 2016 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +16